Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
…, TPL Bijl, HDG van Willigen, E Wynberg, BJ Verkaik… - Elife, 2021 - elifesciences.org
Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …
[HTML][HTML] Sudden cardiac arrest in infants and children: proposal for a diagnostic workup to identify the etiology. An 18-year multicenter evaluation in the Netherlands
AM Bakker, M Albrecht, BJ Verkaik… - European journal of …, 2024 - Springer
Sudden cardiac arrest (SCA) studies are often population-based, limited to sudden cardiac
death, and excluding infants. To guide prevention opportunities, it is essential to be informed …
death, and excluding infants. To guide prevention opportunities, it is essential to be informed …
[HTML][HTML] One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset
…, E Wynberg, A Verveen, M Dijkstra, BJ Verkaik… - Plos one, 2023 - journals.plos.org
Background There is increasing data that show a persistently impaired pulmonary function
upon recovery after severe infection. Little is known however about the extent, recovery and …
upon recovery after severe infection. Little is known however about the extent, recovery and …
[PDF][PDF] A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern
…, A van Nuenen, A van der Veen, B Verkaik… - Cell Reports …, 2022 - cell.com
The urgent need for, but limited availability of, SARS-CoV-2 vaccines worldwide has led to
widespread consideration of dose-sparing strategies. Here, we evaluate the SARS-CoV-2-…
widespread consideration of dose-sparing strategies. Here, we evaluate the SARS-CoV-2-…
Limitation of troponin T In identifying the cause of out-of-hospital cardiac arrest
BJ Verkaik, P Dekkers, T Slagboom, C Van der Werf… - Circulation, 2022 - Am Heart Assoc
Introduction: High Sense-Troponin T (HS-TnT) is a key determinant for presence or absence
of acute MI in chest pain patients (pts). Its value for acute MI diagnosis in pts with out-of-…
of acute MI in chest pain patients (pts). Its value for acute MI diagnosis in pts with out-of-…
The Association Between Ventricular Fibrillation Duration and Successful Termination After the First Shock in Witnessed Out-of-Hospital Cardiac Arrest Patients
BJ Verkaik, R Stieglis, H Tan, H van Schuppen… - Circulation, 2023 - Am Heart Assoc
Introduction: In OHCA patients with an initial shockable rhythm, a longer time interval between
onset of VF and the first shock decreases the likelihood of survival. The exact mechanism …
onset of VF and the first shock decreases the likelihood of survival. The exact mechanism …
Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands
…, A van der Veen, B Verkaik… - Influenza and other …, 2023 - Wiley Online Library
Background We used data from a prospective cohort to explore 2‐year trajectories of ‘long
COVID’ (persistent symptoms after SARS‐CoV‐2 infection) and their association with illness …
COVID’ (persistent symptoms after SARS‐CoV‐2 infection) and their association with illness …
Incidence of True Refractory Ventricular Fibrillation in Patients Meeting a Pragmatic Definition of Refractory Ventricular Fibrillation
BJ Verkaik, RG Walker, R Marx, MM Ekkel, TG Taylor… - Circulation, 2023 - Am Heart Assoc
Introduction: Refractory VF, pragmatically defined as a shockable presenting rhythm that is
still observed after three shocks and associated 2-minute CPR cycles, is often encountered in …
still observed after three shocks and associated 2-minute CPR cycles, is often encountered in …
[BOOK][B] On wind and roughness over land
JW Verkaik - 2006 - search.proquest.com
… , Rushdi El-Kilani; eerder al de “grote” jongens en meisjes, Cor Jacobs, Bart van den Hurk,
Anne Verhoef; en later ook de jonkies, Reinder Ronda, Wouter Meijninger en Bas van de …
Anne Verhoef; en later ook de jonkies, Reinder Ronda, Wouter Meijninger en Bas van de …
Acalabrutinib (ACP-196): a covalent Bruton tyrosine kinase inhibitor with a differentiated selectivity and in vivo potency profile
…, E de Zwart, D Mittag, D Demont, S Verkaik… - … of Pharmacology and …, 2017 - ASPET
Several small-molecule Bruton tyrosine kinase (BTK) inhibitors are in development for B cell
malignancies and autoimmune disorders, each characterized by distinct potency and …
malignancies and autoimmune disorders, each characterized by distinct potency and …